Moving from Tap to Source: Mastering the Radical Shift of the Recast EU Drinking Water Directive (DWD)

Testing water at the tap is no longer enough to guarantee its safety. For decades, material compliance relied on a reactive approach: waiting to test the end-product. The recast EU Drinking Water Directive (DWD) completely shatters this old paradigm, shifting the entire industry from downstream monitoring to a mandatory, upstream risk prevention model.

On June 9, Staphyt hosted an exclusive webinar breaking down the complex web of new rules, shifting roles, and critical timelines that every stakeholder in the water-contact material sector must face.

If your business is still relying on fragmented, legacy national certificates, your supply chain is already exposed to significant regulatory risk. Here is a recap of the core fundamentals covered during the session, and what you need to do next.

1. The Rules: A Proactive Risk-Based Approach

The recast DWD introduces a stark contrast to old, reactive compliance methods. Instead of testing for contamination after a product is manufactured, the new directive mandates an upstream Risk-Based Approach.

Key structural changes include:

• The Unified European Positive List (EUPL): A single, harmonized list of authorized substances for materials coming into contact with drinking water.

• EU Certificate of Conformity (Article 11): A mandatory, streamlined certification process replacing the chaotic patchwork of national systems across EU member states.

2. The Roles: A Cascading Burden of Proof

Under the new framework, the burden of proof has drastically shifted. Compliance is no longer just the concern of the final manufacturer.

Responsibilities now cascade across the entire supply chain:

• Raw Material Suppliers & Economic Operators: Must proactively provide data and ensure compliance before their substances ever enter production.

• Regulatory Authorities: Enforcing stricter, preventative oversight to anticipate and mitigate contamination risks long before water reaches the consumer’s tap.

• The Takeaway: Every link in the supply chain must cooperate. Failure to secure compliant data upstream will halt market access downstream.

3. The Deadlines: The Regulatory Window is Closing NOW

The transition timeline is aggressive, and compliance cannot be delayed. We have officially entered the most critical phase of the directive’s rollout.

• Immediate Deadline (June 2026): This month marks the final absolute deadline for submitting mandatory notifications of intention for the approximately 600 substances set to expire in 2028.

• The 2028 Horizon: If a substance lacks an active, successful notification by the end of this month, it face expiration, leaving your portfolio vulnerable to sudden market withdrawal.